GOG 0264


   TAGS:     Oncology Other

Study Description: The purpose of this study is to find out whether treatment with the drugs paclitaxel and carboplatin work better to control your cancer than treatment with the drugs bleomycin, etopside and cisplatin, which is the standard treatment for your type of cancer. Another purpose of this study is to find out what side effects are caused by treatment with these drug combinations. Another purpose of this study is to examine whether inhibin levels (a blood test) might be a good way to know how someone is responding to treatment. Additionally, more will be learned about this specific type of rare ovarian cancer by studying certain markers and substances.

Contact for Enrollment

    
     (706) 721-2505
    keadams@gru.edu

    Submit Information Online

Principal Investigator: Sharad Ghamande

Eligibility Criteria: Patients must be at least 18 years of age or older. Please visit clinicaltrials.gov for a complete listing of all inclusion criteria.

Compensation: No, subjects will not be compensated.

 

Didn't find a study to participate in?

If you don't see specific studies that interest you, please submit your contact information for future studies.